Welcome!

Open Web Authors: Pat Romanski, PR.com Newswire, David Weinberger, Louis Nauges, Sarah Lake

News Feed Item

DrFirst and Halfpenny Technologies Announce Partnership to Provide CPOE and Results Delivery Capabilities

DrFirst, the nation’s leading e-prescribing and solutions platform provider, and Halfpenny Technologies, the nation’s leading CPOE technology provider for labs and radiology today announced a partnership to embed Halfpenny’s ITF (Integrated Technology Framework) within DrFirst’s Rcopia e-prescribing platform.

The ITF Platform for CPOE and Results Delivery is part of Halfpenny’s Meaningful Use Tool Kit. For DrFirst, Halfpenny is delivering a cloud-based software toolset that provides e-prescribing solution providers like DrFirst as well as electronic health record (EHR) vendors out-of-the-box CPOE and results delivery capabilities that can be rapidly and seamlessly embedded within their workflow and graphical user interface (GUI).

This partnership will allow DrFirst clinical providers to easily navigate to a section of the Rcopia e-prescribing platform and request connectivity to their local or national lab. Halfpenny facilitates the connection between the lab and the Halfpenny ITF-Hub infrastructure so that orders placed in the Rcopia solution are delivered to the lab electronically and results are then delivered back into Rcopia when completed.

”We are delighted to be partnering with Halfpenny Technologies to provide our Rcopia customers CPOE, lab, and radiology results delivery capabilities,” said G. Cameron Deemer, president of DrFirst, Inc. “This partnership allows a doctor to create lab orders and receive lab results in a more efficient manner that allows them quicker access to data. The functionality provided by Halfpenny fills a void for many providers who are looking to adopt additional IT functionality that will allow them to participate in government incentive programs including Meaningful Use Stage 2.”

Tim Kowalski, Halfpenny Technologies’ president & CEO commented, “We are pleased to be partnering with DrFirst and integrating with their industry leading solution. With the finalization of MU2 requirements, the deadline for labs and clinical content vendors to meet these requirements is quickly approaching. Our robust and time-proven Meaningful Use Tool Kit uniquely enables labs and EHR vendors to solve the MU2 challenge without diverting their internal resources from other mission critical initiatives with a cost-effective and technologically robust approach. With DrFirst we are jointly solving this MU2 challenge for a broad base of the provider community.”

About DrFirst, Inc.

Founded in 2000, DrFirst is the nation's leading e-prescribing and solutions platform provider to physician practices, major health plans, health systems, hospitals, and EHR vendors. Through its Open Borders Program, DrFirst provides technology platform solutions to more than 260 EHR, practice management and HIT systems. A Surescripts Gold Certified solution provider for four consecutive years with its award-winning Rcopia electronic prescription management system, DrFirst utilizes the Surescripts network for pharmacy connectivity, health plan information, and patient medication history. For more information visit www.drfirst.com .

About Halfpenny Technologies

Halfpenny Technologies Inc. provides clinical laboratories, hospitals, health plans, health information exchanges and EHR vendors with a cloud based, secure, scalable, vendor-neutral clinical data exchange platform. Our proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and LOINC mapping enables laboratories and hospitals to win new clients and better compete in the HITECH era; health plans to improve HEDIS reporting and STAR ratings, increase revenue and support population-based initiatives; and EHR vendors to include CPOE and results delivery in their solutions and meet Meaningful Use certification requirements. To learn more about Halfpenny Technologies visit the web site: www.halfpenny.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.